This site is under development. For the current active site, go to bcbhub.csic.es.

Orcid Publication

Detalle de: Hundreds of dual-stage antimalarial molecules discovered by a functional gametocyte screen

Title Hundreds of dual-stage antimalarial molecules discovered by a functional gametocyte screen
Abstract

Plasmodium falciparum stage V gametocytes are responsible for parasite transmission, and drugs targeting this stage are needed to support malaria elimination. We here screen the Tres Cantos Antimalarial Set (TCAMS) using the previously developed P. falciparum female gametocyte activation assay ( Pf FGAA), which assesses stage V female gametocyte viability and functionality using Pf s25 expression. We identify over 400 compounds with activities <2 μM, chemically classified into 57 clusters and 33 singletons. Up to 68% of the hits are chemotypes described for the first time as late-stage gametocyte-targeting molecules. In addition, the biological profile of 90 compounds representing the chemical diversity is assessed. We confirm in vitro transmission-blocking activity of four of the six selected molecules belonging to three distinct scaffold clusters. Overall, this TCAMS gametocyte screen provides 276 promising antimalarial molecules with dual asexual/sexual activity, representing starting points for target identification and candidate selection.

Apa Reference Miguel-Blanco, C., Molina, I., Bardera, A.I., Díaz, B., de las Heras, L., Lozano, S., González, C., Rodrigues, J., Delves, M.J., Ruecker, A., Colmenarejo, G., Viera, S., Martínez-Martínez, M.S., Fernández, E., Baum, J., Sinden, R.E. & Herreros, E. (2017). Hundreds of dual-stage antimalarial molecules discovered by a functional gametocyte screen. Nature Communications, 8(1). 10.1038/ncomms15160
Doi 10.1038/ncomms15160
Publication Date 17 May 2017
Publication Type Article
Researcher Gonzalo Colmenarejo
Ontology Genome Assembly
Research Groups
Tools

Suggest changes

Publications are synced automatically from ORCID, so they can't be edited here directly. Spotted something wrong? Let us know below and we'll take care of it.

← Return to Home